Choudhary Narendra S, Saraf Neeraj, Saigal Sanjiv, Soin Arvinder S
Institute of Liver Transplantation and Regenerative Medicine, Medanta, The Medicity, Gurgaon, India.
J Clin Exp Hepatol. 2017 Sep;7(3):247-252. doi: 10.1016/j.jceh.2017.08.001. Epub 2017 Aug 24.
Acute-on chronic liver failure (ACLF) is defined as acute insult on previous liver disease that causes sudden worsening of liver functions.
ACLF is characterized by high incidence of organ failure and prognosis is remarkably worse than patients with cirrhosis. Incidence of organ failures is very high despite best medical care and timely liver transplant before development of multi organ failure is associated with good survival rates.
At present, there are no reliable score or ways to correctly identify patients who are going to recover from patients who will need transplantation. Organ failures are important part of prognosis and to define need or futility of early liver transplantation.
Asian Pacific Association for the Study of the Liver (APASL) published their recommendations regarding ACLF in 2014. Several important studies regarding course/nature of disease and transplantation for ACLF became available after 2014 APASL recommendations and still there are some unanswered areas. The current review discusses various issues regarding liver transplantation in patients with ACLF.
慢加急性肝衰竭(ACLF)被定义为既往肝脏疾病遭受急性损伤,导致肝功能突然恶化。
ACLF的特征是器官衰竭发生率高,其预后明显差于肝硬化患者。尽管给予最佳医疗护理,但器官衰竭的发生率仍然很高,在多器官衰竭发生之前及时进行肝移植与良好的生存率相关。
目前,尚无可靠的评分或方法能够正确区分哪些患者能够康复,哪些患者需要进行移植。器官衰竭是预后的重要组成部分,并且决定了早期肝移植的必要性或徒劳性。
亚太肝脏研究协会(APASL)于2014年发布了关于ACLF的建议。在2014年APASL建议之后,出现了一些关于ACLF疾病进程/性质和移植的重要研究,但仍有一些未解决的领域。本综述讨论了ACLF患者肝移植的各种问题。